SCHEMBL23217910

SCHEMBL23217910

Cc1cccc(C(=O)C(=O)c2ccc3ncc(OCCNC(=O)OC(C)(C)C)cc3c2)n1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
SUCNR1 Q9BXA5 5/20 0.39
PDK2 Q15119 1/20 0.39
ITK Q08881 3/20 0.38
EGFR P00533 2/20 0.38
GABRA5 P31644 1/20 0.38
LATS1 O95835 1/20 0.37
SCN9A Q15858 1/20 0.37
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
BCHE P06276 1/20 0.36
CNR2 P34972 1/20 0.36
F2R P25116 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217900 0.86 GABRA5 (0.38) CA12CA1CA2CA9SUCNR1
SCHEMBL23217905 0.85 CA12 (0.40) CA12CA1CA2CA9SUCNR1
SCHEMBL23217929 0.79 TGFBR1 (0.37) KDM4ETDP1
SCHEMBL23217950 0.78 CA12 (0.48) CA12CA1CA2CA9PDK2
SCHEMBL23217897 0.76 NPC1 (0.34) GABRA5LATS1CKS1BSKP1SKP2
SCHEMBL23217960 0.76 CA12 (0.47) CA12CA1CA2CA9PDK2
SCHEMBL23217953 0.73 PDK2 (0.36) CA12CA1CA2CA9SUCNR1
SCHEMBL23389992 0.72 P2RX7 (0.38)
SCHEMBL29796592 0.72 P2RX7 (0.38)
SCHEMBL30131266 0.71 CA12 (0.49) CA12CA1CA2CA9SUCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2021072330-A1 GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES SILVERBACK THERAPEUTICS, INC. (US) 2021-04-15 WO disclosed